Portage Biotech Stock Target Price and Analyst Consensus
| PRTG Stock | USD 4.13 0.10 2.48% |
The current analyst and expert consensus on Portage Biotech is Hold, with no strong buy opinions. The current projected Portage Biotech target price consensus is 10.00 with 1 analyst opinions. Check out Macroaxis Advice on Portage Biotech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.The most common way Portage Biotech analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Portage Biotech executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Portage Biotech. We encourage you to use your own analysis of Portage Biotech to validate this buy or sell advice. Portage Biotech buy-or-sell recommendation module provides average expert sentiment on the projected Portage Biotech target price to derive its highest and lowest estimates based on projected price volatility of 16.9459.
Lowest Forecast 9.1 | Highest Forecast 11.1 | Target Price 10 |
Portage |
It's important to approach Portage Biotech's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Portage Biotech price targets
Portage Biotech's stock target price is an estimate of its future price, usually made by analysts. Using Portage Biotech's target price to determine if it is a suitable investment can be done through the following steps:- Look at Portage Biotech's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Portage Biotech's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Portage Biotech Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Portage Biotech is a key component of Portage Biotech valuation and have some predictive power on the future returns of a Portage Biotech.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Portage Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | ESG Investing Invested few shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Social Domain Invested few shares | |
 | Driverless Cars Invested over 200 shares | |
 | Adviser Favorites Invested few shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
 | Macroaxis Index Invested few shares | |
 | Hedge Favorites Invested few shares | |
 | Momentum Invested over 40 shares | |
 | Banking Invested over 20 shares | |
 | Large Cap ETFs Invested few shares | |
 | Business Services Invested few shares | |
 | Manufacturing Invested over 30 shares |
Check out Macroaxis Advice on Portage Biotech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.